Moreover, the 36-month beta value for RXST is 1.10. Analysts have varying opinions on the stock, with 4 analysts rating it as a “buy,” 4 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for RXST is 38.25M and currently, short sellers hold a 7.17% of that float. On November 15, 2024, RXST’s average trading volume was 463.99K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
RXST) stock’s latest price update
RxSight Inc (NASDAQ: RXST)’s stock price has dropped by -1.10 in relation to previous closing price of 44.65. Nevertheless, the company has seen a loss of -13.16% in its stock price over the last five trading days. seekingalpha.com reported 2024-11-09 that RxSight, Inc. (NASDAQ:RXST ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Oliver Moravcevic – Vice President, Investor Relations Ron Kurtz – President, Chief Executive Officer Shelley Thunen – Assistant Secretary, Chief Financial Officer Conference Call Participants Lilia Lozada – J.P. Morgan Iseult McMahon – BTIG Lei Huang – Wells Fargo Craig Bijou – Bank of America Young Li – Jefferies Tom Stephan – Stifel Steven Lichtman – Oppenheimer & Co. Inc. David Saxon – Needham & Company Operator Thank you for standing by.
RXST’s Market Performance
RXST’s stock has fallen by -13.16% in the past week, with a monthly drop of -12.83% and a quarterly drop of -16.35%. The volatility ratio for the week is 6.75% while the volatility levels for the last 30 days are 4.46% for RxSight Inc. The simple moving average for the past 20 days is -10.99% for RXST’s stock, with a -16.45% simple moving average for the past 200 days.
Analysts’ Opinion of RXST
Many brokerage firms have already submitted their reports for RXST stocks, with Jefferies repeating the rating for RXST by listing it as a “Buy.” The predicted price for RXST in the upcoming period, according to Jefferies is $72 based on the research report published on October 29, 2024 of the current year 2024.
Needham, on the other hand, stated in their research note that they expect to see RXST reach a price target of $66, previously predicting the price at $54. The rating they have provided for RXST stocks is “Buy” according to the report published on August 20th, 2024.
Needham gave a rating of “Buy” to RXST, setting the target price at $54 in the report published on August 06th of the current year.
RXST Trading at -12.52% from the 50-Day Moving Average
After a stumble in the market that brought RXST to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -33.63% of loss for the given period.
Volatility was left at 4.46%, however, over the last 30 days, the volatility rate increased by 6.75%, as shares sank -11.73% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -17.46% lower at present.
During the last 5 trading sessions, RXST fell by -13.16%, which changed the moving average for the period of 200-days by -2.97% in comparison to the 20-day moving average, which settled at $49.61. In addition, RxSight Inc saw 9.52% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at RXST starting from Goldshleger Ilya, who sale 1,330 shares at the price of $46.13 back on Nov 12 ’24. After this action, Goldshleger Ilya now owns 42,246 shares of RxSight Inc, valued at $61,356 using the latest closing price.
Corley Jesse Anderson, the Director of RxSight Inc, purchase 11,111 shares at $45.37 during a trade that took place back on Nov 12 ’24, which means that Corley Jesse Anderson is holding 468,571 shares at $504,079 based on the most recent closing price.
Stock Fundamentals for RXST
Current profitability levels for the company are sitting at:
- -0.28 for the present operating margin
- 0.63 for the gross margin
The net margin for RxSight Inc stands at -0.22. The total capital return value is set at -0.14. Equity return is now at value -13.99, with -12.47 for asset returns.
Currently, EBITDA for the company is -41.04 million with net debt to EBITDA at 0.2. When we switch over and look at the enterprise to sales, we see a ratio of 12.82. The receivables turnover for the company is 5.46for trailing twelve months and the total asset turnover is 0.45. The liquidity ratio also appears to be rather interesting for investors as it stands at 12.67.
Conclusion
To wrap up, the performance of RxSight Inc (RXST) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
